Covered recipient · General Payments record
SHEETAL R JOSHI
Allopathic & Osteopathic Physicians Psychiatry & Neurology Psychiatry
General Payments · PY2018–2022
$2,057.73
- Reported across 150 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2022 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $174.50 | 9 |
By paying entity
PY2022 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | $71.62 | 3 |
| Janssen Pharmaceuticals, Inc | $23.68 | 1 |
| Neurocrine BioSciences, Inc. | $19.99 | 1 |
| Alkermes, Inc. | $18.32 | 1 |
| Lundbeck LLC | $14.75 | 1 |
| Takeda Pharmaceuticals U.S.A., Inc. | $14.04 | 1 |
| Teva Pharmaceuticals USA, Inc. | $12.10 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2022 (9)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Alkermes, Inc. | $18.32 | 06/24/2022 | Food and Beverage | Undisputed | 01/23/2026 | 925876429 | CMS |
| Janssen Pharmaceuticals, Inc | $23.68 | 05/13/2022 | Food and Beverage | Undisputed | 01/23/2026 | 886784337 | CMS |
| Lundbeck LLC | $14.75 | 03/26/2022 | Food and Beverage | Undisputed | 01/23/2026 | 945763115 | CMS |
| Neurocrine Biosciences, Inc. | $19.99 | 05/06/2022 | Food and Beverage | Undisputed | 01/23/2026 | 963305899 | CMS |
| Otsuka America Pharmaceutical, Inc. | $23.45 | 02/12/2022 | Food and Beverage | Undisputed | 01/23/2026 | 929298537 | CMS |
| Otsuka America Pharmaceutical, Inc. | $23.84 | 03/11/2022 | Food and Beverage | Undisputed | 01/23/2026 | 929298539 | CMS |
| Otsuka America Pharmaceutical, Inc. | $24.33 | 04/29/2022 | Food and Beverage | Undisputed | 01/23/2026 | 929298541 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $14.04 | 02/25/2022 | Food and Beverage | Undisputed | 01/23/2026 | 955672525 | CMS |
| Teva Pharmaceuticals USA, Inc. | $12.10 | 05/21/2022 | Food and Beverage | Undisputed | 01/23/2026 | 954882915 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022
- Generated from
- OP_DTL_GNRL_PGYR2022_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.